The effects and costs of a multidisciplinary symptomatic treatment strategy on quality of life of people severely affected by MS

Recruiting

• Conditions: Multiple Sclerosis; 10012303

• Registration Number: NL-OMON44570
• Lead Sponsor: Vrije Universiteit Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 78

Inclusion Criteria

a referral to Nieuw Unicum and a diagnosis Multiple Sclerosis

Exclusion Criteria

Individuals who are mentally incompetent to give informed consent will not be included in the study.

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The change in quality of life, caregivers burden and functional domains from<br /><br>baseline to endpoint will be evaluated. The primary outcome parameters are the<br /><br>Euroqol (EQ-5d-5l) and the Adult Social Care Outcome Toolkit (ASCOT) for<br /><br>respectively health-related- and social related quality of life. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>1. Disability (meetinstrumenten: Functional independent measure en Multiple<br /><br>Sclerosis Impact Profile)<br /><br><br /><br>2. Caregiver strenght (Caregiver Strain Index)<br /><br><br /><br>3. Costs (Medical Consumption Questionnaire)</p><br>